Results 111 to 120 of about 57,806 (244)

Caveolin-1 Phosphorylation Is Essential for Axonal Growth of Human Neurons Derived From iPSCs. [PDF]

open access: yes, 2019
Proper axonal growth and guidance is essential for neuron differentiation and development. Abnormal neuronal development due to genetic or epigenetic influences can contribute to neurological and mental disorders such as Down syndrome, Rett syndrome, and
Almenar-Queralt, Angels   +8 more
core   +1 more source

Citron binds to PSD-95 at glutamatergic synapses on inhibitory neurons in the hippocampus [PDF]

open access: yes, 1999
Synaptic NMDA-type glutamate receptors are anchored to the second of three PDZ (PSD-95/Discs large/ZO-1) domains in the postsynaptic density (PSD) protein PSD-95.
Apperson, Michelle   +3 more
core   +1 more source

Natural Products Targeting the EGFR/HER2 Axis in Tumorigenesis: Interpretation of Molecular Mechanisms and Recent Insights Into Synergistic Strategies for Cancer Therapy

open access: yesFood Frontiers, Volume 7, Issue 1, January 2026.
Schematic overview illustrating the anticancer mechanisms of selected natural products (resveratrol, quercetin, berberine) targeting EGFR and HER2 signaling pathways in tumor cells. These compounds inhibit receptor activation and downstream oncogenic cascades, including PI3K/Akt/mTOR, MAPK/ERK, and STAT3 pathways.
Iman Ramli   +8 more
wiley   +1 more source

Loss of ARHGEF6 Causes Hair Cell Stereocilia Deficits and Hearing Loss in Mice

open access: yesFrontiers in Molecular Neuroscience, 2018
ARHGEF6 belongs to the family of guanine nucleotide exchange factors (GEFs) for Rho GTPases, and it specifically activates Rho GTPases CDC42 and RAC1.
Chengwen Zhu   +35 more
doaj   +1 more source

Melanoma: Pathogenesis and Targeted Therapy

open access: yesMedComm, Volume 7, Issue 1, January 2026.
The treatment landscape for advanced melanoma has evolved significantly. BRAF–MEK inhibitor combinations are standard for BRAF‐mutant melanoma, whereas targeting NRAS mutations is more challenging, with MEK inhibitors like tunlametinib emerging as an option.
Yang Fu   +5 more
wiley   +1 more source

Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.

open access: yesPLoS ONE, 2018
Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality in American women. Normal ovarian physiology is intricately connected to small GTP binding proteins of the Ras superfamily (Ras, Rho, Rab, Arf, and Ran) which govern processes
Madalene Earp   +148 more
doaj   +1 more source

Vascular smooth muscle contraction in hypertension [PDF]

open access: yes, 2018
Hypertension is a major risk factor for many common chronic diseases, such as heart failure, myocardial infarction, stroke, vascular dementia and chronic kidney disease.
Alves-Lopes, Rheure   +6 more
core   +1 more source

Extensile Active Hydrogels Driven by Living FtsZ Polymers

open access: yesSmall, Volume 22, Issue 3, 13 January 2026.
Upon post‐gelation activation with Mg2⁺/GTP, living FtsZ polymers treadmill inside a polyacrylamide network, generating extensile internal stresses that drive isotropic swelling and softening. Interpreting mechanics against a Flory–Rehner swelling baseline separates passive dilution from genuine activity, revealing an FR‐normalized permittivity that ...
Mikheil Kharbedia   +8 more
wiley   +1 more source

PACAP induces FSHβ gene expression via EPAC. [PDF]

open access: yes, 2019
Gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), are heterodimers of a common α subunit and unique β subunits. Regulation of their levels, primarily by GnRH, is critical for reproductive function.
Coss, Djurdjica, Yeh, Debra M
core  

Sensor potency of the moonlighting enzyme-decorated cytoskeleton [PDF]

open access: yes, 2013
Background: There is extensive evidence for the interaction of metabolic enzymes with the eukaryotic cytoskeleton. The significance of these interactions is far from clear.
Amar Patrick   +5 more
core   +4 more sources

Home - About - Disclaimer - Privacy